For reprint rights or to purchase a copy of your Daily Journal photo, email Jeremy_Ellis@dailyjournal.com for prices or call 213-229-5424.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Securities

Mar. 21, 2014

Cooley, Wilson Sonsini brought on for $115M pharma IPO

Cooley LLP and Wilson Sonsini Goodrich & Rosati PC attorneys in Seattle and Palo Alto are helping to take antibody drug developer Alder BioPharmaceuticals Inc. public in an offering that could net the company up to $115 million


By Dominic Fracassa


Daily Journal Staff Writer


PALO ALTO - Alder BioPharmaceuticals Inc., a developer of therapeutic antibodies, brought on Cooley LLP to help guide the company through its planned initial public offering.


In its public filing with the Securities and Exchange Commission on Wednesday, the Bothell, Wash.-based company said it plans to raise up to $115 million through the offering. Share volume and pricing information were not di...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.